Once-Daily Fluticasone Propionate is as Effective as Twice-Daily Treatment in Stable, Mild-to-Moderate Childhood Asthma

被引：0
|
作者：
Ian G. C. Hodges
Thelma A. Netherway
机构：
[1] Royal Glamorgan Hospital,Consultant Paediatrician
[2] Ynysmaerdy,undefined
[3] Glaxo SmithKline UK Ltd,undefined
来源：
Clinical Drug Investigation | 2005年 / 25卷
关键词：
Fluticasone Propionate; Salmeterol; Peak Expiratory Flow; Morning Peak Expiratory Flow; Evening Peak Expiratory Flow;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: To test the hypothesis that once-daily treatment with fluticasone propionate is as effective as twice-daily treatment in children with well controlled asthma.
引用
收藏
页码：13 / 22
页数：9
相关论文
共 50 条
  • [1] Once-daily fluticasone propionate is as effective as twice-daily treatment in stable, mild-to-moderate childhood asthma
    Hodges, IGC
    Netherway, TA
    CLINICAL DRUG INVESTIGATION, 2005, 25 (01) : 13 - 22
  • [2] Once daily inhaled fluticasone propionate is as effective as twice daily in children with stable mild to moderate asthma
    Hodges, I
    Netherway, T
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A139 - A139
  • [3] Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma
    Woodcock, Ashley
    Bleecker, Eugene R.
    Busse, William W.
    Lotvall, Jan
    Snowise, Neil G.
    Frith, Lucy
    Jacques, Loretta
    Haumann, Brett
    Bateman, Eric D.
    RESPIRATORY RESEARCH, 2011, 12
  • [4] Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma
    Ashley Woodcock
    Eugene R Bleecker
    William W Busse
    Jan Lötvall
    Neil G Snowise
    Lucy Frith
    Loretta Jacques
    Brett Haumann
    Eric D Bateman
    Respiratory Research, 12
  • [5] Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma
    Kemp, JP
    Berkowitz, RB
    Miller, SD
    Murray, JJ
    Nolop, K
    Harrison, JE
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 106 (03) : 485 - 492
  • [6] Once-daily administration of budesonide Turbuhaler® was as effective as twice-daily treatment in patients with mild to moderate persistent asthma
    Mintz, S
    Alexander, M
    Li, JHS
    Mayer, PV
    JOURNAL OF ASTHMA, 2002, 39 (03) : 203 - 210
  • [7] ONCE-DAILY FLUTICASONE PROPIONATE IS AS EFFECTIVE FOR PERENNIAL ALLERGIC RHINITIS AS TWICE-DAILY BECLOMETHASONE DIPROPRIONATE
    VANAS, A
    BRONSKY, EA
    DOCKHORN, RJ
    GROSSMAN, J
    LUMRY, W
    MELTZER, EO
    SELTZER, JM
    ROGENES, PR
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (06) : 1146 - 1154
  • [8] ONCE-DAILY VS TWICE-DAILY NITRENDIPINE IN THE TREATMENT OF MILD TO MODERATE HYPERTENSION
    BOLLI, P
    COBBY, J
    HANDA, SP
    LAPLANTE, LE
    MUKHERJEE, J
    RABIN, EZ
    STRONG, HA
    WRIGHT, JM
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 : S182 - S185
  • [9] ADHERENCE WITH ONCE-DAILY FLUTICASONE FUROATE/VILANTEROL COMPARED TO TWICE-DAILY BUDESONIDE/FORMOTEROL OR FLUTICASONE PROPIONATE/SALMETEROL IN ASTHMA
    Averell, C.
    Stanford, R.
    Laliberte, F.
    Wu, J.
    Germain, G.
    Duh, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S39 - S39
  • [10] LONG-TERM EFFECTS OF ONCE-DAILY MOMETASONE FUROATE, TWICE-DAILY FLUTICASONE PROPIONATE, AND ONCE-DAILY MONTELUKAST ON BONE MINERAL DENSITY IN PATIENTS WITH MILD ASTHMA
    Maspero, J.
    Backer, V.
    Yao, R.
    Teper, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A41 - A41
12345